SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following NOAA's determination that its consolidated deep-seabed mining application, including an expanded recovery area, is in substantial compliance. The community sees this as a crucial de-risking step, emphasizing the company's role in securing critical minerals for U.S. national security amidst global geopolitical shifts.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the CEO's recent remarks about "curative outcomes" for its AML immunotherapy, GPS, ignite strong community conviction and discussions of a substantial short squeeze and potential buyout. Investors are actively interpreting extended patient survival in the ongoing trial as a highly positive signal, alongside significant call option activity suggesting large upside potential.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending after recently delivering a strong Q4 2025 earnings beat driven by robust MIPLYFFA sales and anticipated EMA approval, while the community actively discusses the implications of an adverse lawsuit ruling and upcoming Nasdaq bell ringing amidst calls for management to unlock further shareholder value.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid escalating global tensions, which underscore the strategic importance of its heavy rare earth project in Greenland for Western defense and supply chain independence. The community is highly bullish, anticipating a forthcoming Bankable Feasibility Study update to reveal a significantly higher valuation for the Tanbreez asset, challenging current market pricing.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is heavily discussed due to recent share offerings and concerns about its revenue's sensitivity to future interest rate changes, even as bullish momentum builds from rapidly expanding USDC circulation driven by its growing adoption for AI agent payments and tokenized asset transactions.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending following its selection for the White House's Air Taxi Program, which greenlights U.S. operations in 2026, and the launch of Uber Air in Dubai for bookings, fueling community discussion around its accelerated path to commercialization and potential for a significant short squeeze in the evolving eVTOL market.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is trending with a massive volume spike and price surge, fueled by news of a $40 million private placement financing. The community is actively debating whether this represents a sustainable breakout for the volatile biotech, with some anticipating a short squeeze while others caution against a quick pump and dump.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending as a competitor's oral SERD drug failure in late-stage breast cancer trials pivots market attention to OLMA's palazestrant as a potentially best-in-class asset. This shift, along with strong analyst backing and high institutional ownership, is fueling community speculation regarding its acquisition potential and future market leadership despite a recent share offering.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is trending amid significant Middle East geopolitical disruptions, including the Strait of Hormuz closure and a major Qatar LNG facility shutdown, which has sparked a bullish "rip" sentiment as many believe the market is underpricing the potential for prolonged supply chain issues. While some traders anticipate a sustained rally, others remain cautious due to upcoming seasonal demand shifts and historical volatility in natural gas futures.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending with strong community engagement, driven by its unique "Whats UpDog?" meme and ongoing celebration of its established presence on the Solana blockchain. Enthusiasts are actively encouraging new participants to join and "load" into the token, highlighting its long-term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: First Financial Bankshares (NASDAQ:FFIN) Director Buys $53,136.00 in Stock

First Financial Bankshares, Inc. (NASDAQ:FFIN - Get Free Report) Director Sally Pope Davis bought 1,800 shares of the company's stock in a transaction that occurred on Friday, March 6th. The stock...

Insider Buying: First Financial Bankshares (NASDAQ:FFIN) Director Buys 4,000 Shares of Stock

First Financial Bankshares, Inc. (NASDAQ:FFIN - Get Free Report) Director Johnny Trotter purchased 4,000 shares of the business's stock in a transaction dated Thursday, March 5th. The shares were...

First Financial Bankshares (NASDAQ:FFIN) Director Johnny Trotter Acquires 4,000 Shares

First Financial Bankshares, Inc. (NASDAQ:FFIN - Get Free Report) Director Johnny Trotter purchased 4,000 shares of the stock in a transaction on Thursday, March 5th. The stock was acquired at an...

First Financial Bankshares (NASDAQ:FFIN) Hits New 52-Week Low - What's Next?

First Financial Bankshares (NASDAQ:FFIN) Sets New 1-Year Low - Here's What Happened...

Royce & Associates LP Sells 100,620 Shares of First Financial Bankshares, Inc. $FFIN

Royce & Associates LP lessened its stake in First Financial Bankshares, Inc. (NASDAQ:FFIN - Free Report) by 39.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with...

JPMorgan Chase & Co. Has $15.90 Million Stake in First Financial Bankshares, Inc. $FFIN

JPMorgan Chase & Co. increased its position in shares of First Financial Bankshares, Inc. (NASDAQ:FFIN - Free Report) by 40.3% in the 3rd quarter, according to the company in its most recent 13F...

First Financial Bankshares Inc Has $62.59 Million Stake in Meta Platforms, Inc. $META

First Financial Bankshares Inc increased its position in Meta Platforms, Inc. (NASDAQ:META - Free Report) by 8.6% during the third quarter, according to the company in its most recent 13F filing with...

First Financial Bankshares Inc Sells 65,621 Shares of JPMorgan Chase & Co. $JPM

First Financial Bankshares Inc lowered its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 8.3% in the third quarter, according to its most recent filing with the Securities and Exchange...

Vanguard Group Inc. Decreases Stock Holdings in First Financial Bankshares, Inc. $FFIN

Vanguard Group Inc. lessened its stake in shares of First Financial Bankshares, Inc. (NASDAQ:FFIN - Free Report) by 0.9% during the third quarter, according to the company in its most recent 13F...

First Financial Bankshares Inc Sells 604,145 Shares of SLB Limited $SLB

First Financial Bankshares Inc reduced its stake in SLB Limited (NYSE:SLB - Free Report) by 98.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned...

First Financial Bankshares, Inc. is a holding company, which engages in the provision of financial and community banking services. It offers mortgage loans, savings and checking accounts, auto and equity loans, online and mobile banking, investment and trust management, and retirement plans. The company was founded in 1956 and is headquartered in Abilene, TX.

Current Price	$30.26
Prev Close	$30.08
Open	$29.71
Dividend Yield	2.51%
50-Day Moving Average	$32.12
Beta	1.08
Avg. Volume	735,180.03
PE Ratio	17.02

52-Week High	$38.74
52-Week Low	$28.89
Market Capitalization	$4.34B
EPS (Annual)	$1.77
Price to Book	2.23
Revenue Per Employee	$522,418.75

FFIN
First Financial Bankshares, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FFIN News

FFINFirst Financial Bankshares, Inc.